828. Short- and Long-Term Metabolic Changes in Virologically Suppressed Patients Switching from TDF to TAF Containing Antiretroviral Therapy

BACKGROUND: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) containing antiretroviral therapy (ART) may negatively influence weight, cholesterol, and atherosclerotic cardiovascular disease (ASCVD) risk. The timing, duration, and extent of these changes and their def...

Descripción completa

Detalles Bibliográficos
Autores principales: Schafer, Jason J, Zimmerman, Matty, Walshe, Ciara E, Cerankowski, Jessie, Shimada, Ayako, Keith, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643897/
http://dx.doi.org/10.1093/ofid/ofab466.1024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643897/
http://dx.doi.org/10.1093/ofid/ofab466.1024

Ejemplares similares